GlassScriptPhysician profile
Robert J Kiltz
NPI 1346309549
$6,491.31
in general payments reported to CMS, 2019-2025
26 companies · $320 in 2025
The $320 reported for 2025 was more than what 79% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,506 · 2020: $752 · 2021: $1,280 · 2022: $949 · 2023: $1,002 · 2024: $683 · 2025: $320.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,005.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,481.86 | 2019-2023 | |
| Organon LLC | $1,480.36 | 2021-2025 | Follistim Aq, Ganirelix Acetate, Pregnyl |
| Ferring Pharmaceuticals INC. | $1,240.32 | 2019-2025 | Menopur |
| Merck Sharp & Dohme LLC | $481.84 | 2019-2021 | |
| Coopersurgical, INC. | $312.79 | 2021-2025 | Stripper |
| Emd Serono, INC. | $305.35 | 2019-2022 | |
| Vitrolife INC. | $200.73 | 2019-2020 | |
| Myovant Sciences INC. | $161.20 | 2021-2022 | |
| Ge Healthcare | $157.82 | 2019-2024 | |
| Lupin INC. | $116.91 | 2019 | |
| Sumitomo Pharma America, INC. | $112.39 | 2023-2025 | Myfembree |
| Teleflex LLC | $75.40 | 2019 | |
| Duchesnay USA Incorporated | $52.86 | 2019 | |
| Cook Medical LLC | $47.33 | 2022-2023 | Guardia |
| Amag Pharmaceuticals, INC. | $37.43 | 2019-2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $37.06 | 2025 | Dexcom G6 Transmitter |
| Pfizer INC. | $29.69 | 2023-2024 | |
| Amneal Pharmaceuticals LLC | $29.15 | 2024 | Unithroid |
| Kowa Pharmaceuticals America, INC. | $26.09 | 2022-2023 | Seglentis |
| Hamilton Thorne, INC. | $21.24 | 2025 | Lykos, Lenshooke Semen Quality Analyzer, Cook |
| Guerbet LLC | $16.86 | 2019 | |
| Covidien LP | $15.78 | 2019 | |
| Exeltis, USA INC. | $14.31 | 2019 | |
| Hologic Sales and Service, LLC | $13.75 | 2019 | |
| Avion Pharmaceuticals | $13.13 | 2021 | |
| Meditrina | $9.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kiltz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.